Company News: Page (1) of 1 - 02/12/18 Email this story to a friend. email article Print this page (Article printing at page facebook

AbbVie Showcases New, Late-Breaking Investigational Data at 2018 American Academy of Dermatology (AAD) Annual Meeting

- Fourteen presentations of HUMIRA® (adalimumab) and pipeline data demonstrate AbbVie's extensive dermatology portfolio and continued commitment to patients living with immune-mediated diseases (February 12, 2018)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Pro AV,Presentors,Business Issues,Presentation,People,Events,USA,Medicine,Disease,Surgery,Cancer,Surgery,Medication,Physician,Science,Lifestyle,Medical,Cancer,Science,Adults,Children,Other,


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved